The MSIS-29 and SF-36 as outcomes in secondary progressive MS trials
- Eva M. M. Strijbis
- , Pavle Repovic
- , Jop Mostert
- , James D. Bowen
- , Bernard M. J. Uitdehaag
- , Gary Cutter
- , Marcus W. Koch*
*Corresponding author for this work
- Amsterdam UMC - University of Amsterdam
- Swedish Medical Center
- Rijnstate Hospital
- University of Alabama at Birmingham
- University of Calgary
- Amsterdam University Medical Centers
Research output: Contribution to journal › Article › Academic › peer-review
11
Downloads
(Pure)